Showing results (1-10 of 219) with videos related to
Sort By:
Pageof 22
Seminars in Immunopathology|September 19, 2009
Novel approaches for identifying target antigens of autoreactive human B and T cellsKlaus Dornmair, Edgar Meinl, Reinhard HohlfeldAnnals of Neurology|May 24, 2006
B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulationEdgar Meinl, Markus Krumbholz, Reinhard HohlfeldJournal of Neurology|March 18, 2005
Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell responseTobias Derfuss, Reinhard Hohlfeld, Edgar MeinlJournal of the Neurological Sciences|August 19, 2008
B- and T-cell responses in multiple sclerosis: novel approaches offer new insightsReinhard Hohlfeld, Edgar Meinl, Klaus DornmairNeurology|July 20, 2007
Dual role of inflammation in CNS diseaseReinhard Hohlfeld, Martin Kerschensteiner, Edgar MeinlNature Reviews. Neurology|December 15, 2010
The emerging role of microRNAs in multiple sclerosisAndreas Junker, Reinhard Hohlfeld, Edgar MeinlResults and Problems in Cell Differentiation|April 4, 2009
Neuro-immune crosstalk in CNS diseasesMartin Kerschensteiner, Edgar Meinl, Reinhard HohlfeldJournal of the Neurological Sciences|June 1, 2012
Viability of autoantibody-targets: how to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosisMarie Cathrin Mayer, Reinhard Hohlfeld, Edgar MeinlThe Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational researchReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.The Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targetsReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.Pageof 22